News

Groundbreaking culturing technique reveals crucial mechanics of cancer

Researchers have developed a novel cell culturing technique that reveals the hidden biomechanics of breast cancer — the end goal, “radical improvement” in the laborious process of screening chemotherapeutics.
Tutkimuslaitteistoa ja muovihansikkaisiin puetut kädet.
Image: Joonas Lehtovaara / Aalto University

Developing chemotherapy drugs against breast cancer is costly, slow, and often inefficient, with more than 95% of screened drug candidates failing in patient trials. A groundbreaking technique for 3D cell culturing, developed by researchers at Finland’s Aalto University, offers unprecedented insight into the spread of cancer cells through tissue. The technique paves the way to improved efficacy in screening for chemotherapy drug candidates, potentially enabling the screening out of non-viable drug candidates much earlier in the process.

Moving beyond conventional, 2D cell cultures, the biomechanical analysis technique allows breast cancer cells to be grown within 3D cell culture material that more accurately mimics the structures of human tissue, explains principal investigator Juho Pokki

Kuusi tutkimusryhmän jäsentä kuvassa.
Juho Pokki (on the right) with members of the research group (backrow from the left) Ossi Arasalo, Väinö Mäntylä, Linda Srbova and (frontrow) Arttu Lehtonen and Mari Kielosto. Image: Joonas Lehtovaara / Aalto University

“Cancer cells actually feel the tissue that they’re in, and they can change their behaviour based on their surroundings. When they move at different speeds they sense distinct stresses. Stresses can be the difference between the cancer spreading or its movement being mechanically blocked,” says Pokki.

After chemotherapy, residual cancer cells may remain in the tissue and start to move, causing the cancer to recur. The research aims to control the properties of the extracellular matrix (ECM) that cancer cells use to move, investigating how to stop these residual cancer cells.

One version of this novel technique was recently announced in the journal of Soft Matter.

The “grab push, pull and pull” of breast cancer cells 

Breast cancer is the most prevalent cancer in women worldwide and forms the focus of the team’s research. In 2024 more than 300,000 people will receive a breast cancer diagnosis in the United States. Meanwhile, the most common cancers, breast, prostate and bowel cancer, kill more than 300,000 people in the European Union every year. 

A biomechanical researcher and biomedical engineer who came to Aalto University via Stanford University and ETH Zurich, Pokki’s culturing technique allows researchers to account for variability of the ECM, either between cell culture samples or within the same sample. 

“Our analysis allows us to take into account variations in the rigidity of tissue — particularly the related “stiffness” — and how this affects the way cancer cells grab and push and pull through the body, even following in each other’s paths where there is less resistance,” explains Pokki. 

Researchers have for some time understood that the variable stiffness of the ECM is important when it comes to cancer spreading. However, they have hitherto lacked the tools to accurately measure the biomechanics of this cell movement, limiting their ability to capitalise fully on a deeper biomechanical understanding of cell behaviour. 

Illustration of spreading cancer cells.
In spreading breast cancer, cancer cells move from a tumor to the surrounding tissues, and potentially entering blood vessels and creating secondary tumors elsewhere in the body. Image: Pokki Lab

Biomechanics and drug resistance

The innovation is particularly timely, given that recent studies show not only an important relationship between the biomechanical properties of the ECM and the spread of cancer cells, but also a relationship between tissue stiffness and drug resistance. 

“Not only does the biomechanical nature of human tissue affect how cancer spreads, but it also impacts its response to a drug. Essentially, it can take in a drug or spit it out, depending on its mechanical environment,” says Pokki. 

“This new approach has the potential to radically improve drug screening for chemotherapy candidates. It’s an important step on the path towards faster discovery of chemotherapeutics for cancer patients.” 

Pokki and his team have already been researching this cell-scale analysis technique for 5 years. The next phase of study focuses on using their microscopy-integrated tools towards improving drug efficacy testing of chemotherapeutics. 

More information:

Dr. Juho Pokki
[email protected]
tel. +358 50 327 7999
 

Read more:

Havainnekuva rintasyöpäsoluista mikroskoopissa

Breast cancer cells use forces to open up channels through tissue

A new method reveals that cancer cells can spread by rapidly applying forces to tissue material.

News
  • Published:
  • Updated:

Read more news

Aaltocell Excellence
Research & Art Published:

Bio-based opacifiers offer solutions to cleaner environment

The CELLIGHT project, backed by approx. €1.3 million in funding from Business Finland, aims to develop cellulose-based alternatives to titanium dioxide (TiO2 ), a widely used whitener in paints, cosmetics, and coatings.
Metsähovi radio observatory
Cooperation Published:

The kick-off of the Astrophysics Centre for Multimessenger studies in Europe

ACME is an EU-funded project built by and for the astroparticle and the astronomy communities.
Peter Liljeroth
Press releases, Research & Art Published:

Major European funding for research into new quantum materials

New materials are hoped to become building blocks for yet unseen quantum devices
A woman with blonde hair stands with arm resting on a ledge with a grey background.
Appointments Published:

Physics professor: Nuclear simulations need powerful computers, and ‘Finland is at the forefront’

Andrea Sand leads the Nuclear Materials and Engineering research group – a large team of international researchers with funding resources and collaboration opportunities spanning the European continent.